Viewing Study NCT04556266

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:20 PM
Ignite Modification Date: 2026-02-03 @ 9:13 AM
Study NCT ID: NCT04556266
Status: WITHDRAWN
Last Update Posted: 2025-05-13
First Post: 2020-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
None Lymphoma, B-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Lymphoma View
None Lymphoma, B-Cell View
None Chimeric Antigen Receptor (CAR) T cells View
None CART cells View
None high-risk B-cell malignancies View
None 17-331 View
None Memorial Sloan Kettering Cancer Center View